Replies to post #136047 on Elite Pharmaceuticals Inc (ELTP)

[lasers]

Thxs for the link. Difficult to say exactly what these process developments are. The only meaningful at this time IMO is 24 HR Oxy ADT ELI216 which should follow with trialing after 12 ER Oxy ELI201 has been approved and the FDA exactly states what data they want for ELI216.

With ADTs ELI200, ELI202, ELI201, and ELI216 approvals, there would be no need for additional ADTs.

As a pure guess, it is possible that ELTP is developing opioid co-drugs which could use the 400, 500, 600 nomenclature.